ATAI Life Sciences N.V (NASDAQ: ATAI) on Friday, soared 17.52% from the previous trading day, before settling in for the closing price of $1.37. Within the past 52 weeks, ATAI’s price has moved between $1.02 and $2.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -16.02%. The company achieved an average annual earnings per share of -215.43%. With a float of $117.06 million, this company’s outstanding shares have now reached $166.03 million.
Let’s determine the extent of company efficiency that accounts for 83 employees. In terms of profitability, gross margin is 8.59%, operating margin of -36383.85%, and the pretax margin is -43922.34%.
ATAI Life Sciences N.V (ATAI) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ATAI Life Sciences N.V is 30.24%, while institutional ownership is 7.20%. The most recent insider transaction that took place on Sep 26 ’24, was worth 16,093,000. In this transaction 10% Owner of this company sold 2,660,000 shares at a rate of $6.05, taking the stock ownership to the 6,905,774 shares. Before that another transaction happened on May 16 ’24, when Company’s See Remarks sold 151,303 for $1.92, making the entire transaction worth $290,502. This insider now owns 328,697 shares in total.
ATAI Life Sciences N.V (ATAI) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -215.43% per share during the next fiscal year.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
ATAI Life Sciences N.V (ATAI) is currently performing well based on its current performance indicators. A quick ratio of 5.81 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 962.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
Looking closely at ATAI Life Sciences N.V (NASDAQ: ATAI), its last 5-days average volume was 3.27 million, which is a jump from its year-to-date volume of 1.17 million. As of the previous 9 days, the stock’s Stochastic %D was 65.45%. Additionally, its Average True Range was 0.14.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 86.57%, which indicates a significant decrease from 93.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 121.03% in the past 14 days, which was higher than the 73.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2100, while its 200-day Moving Average is $1.5588. However, in the short run, ATAI Life Sciences N.V’s stock first resistance to watch stands at $1.6967. Second resistance stands at $1.7833. The third major resistance level sits at $1.9167. If the price goes on to break the first support level at $1.4767, it is likely to go to the next support level at $1.3433. Should the price break the second support level, the third support level stands at $1.2567.
ATAI Life Sciences N.V (NASDAQ: ATAI) Key Stats
Market capitalization of the company is 317.49 million based on 167,802K outstanding shares. Right now, sales total 310 K and income totals -40,220 K. The company made 270 K in profit during its latest quarter, and -57,310 K in sales during its previous quarter.
